King J

Johnson and Johnson Australia, Khartoum Rd, Macquarie Park, New South Wales, 2113, Australia.

3 papers · ORCID

ArticleKetamine

Quality of life and productivity among esketamine responders in a real-world study in Australia and New Zealand.

Hopwood M, Codyre D, Barton D +4

Europe PMC2026
ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): commentary, Joks et al.

Joks G, Su S, King J

Europe PMC2024
ArticleKetamine

Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel.

Thornton NLR, Black W, Bognar A +10

Europe PMC2023